Concord Asset Management (Virginia)’s Regeneron Pharmaceuticals REGN Stock Holding History

Concord Asset Management (Virginia)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$1.33M	Buy
2024 Q4	$917K	Buy
2024 Q3	$1.12M	Buy
2024 Q2	$959K	Buy
2024 Q1	$504K	Buy
2023 Q4	$418K	Buy